Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Nanox Announces First Quarter of 2024 Financial Results and Provides Business Update
-
Latest Survey from Grayscale Investments® and The Harris Poll Uncovers Likely American Voters Increasingly Becoming Crypto Investors
-
CryptoHeap to Include Major Cryptocurrencies in Updated Staking Options
-
Lantheus to Present at the William Blair 44th Annual Growth Stock Conference
-
DYPER™ Announces Appointment of Giusy Buonfantino as New CEO
-
Tokio Marine HCC – Specialty Group and Susan G. Komen® Pair Up With World No. 1 Golfer Nelly Korda to Help End Breast Cancer
-
Invitation to ScottsMiracle-Gro’s “Meet the Management” Investor Day in Marysville, Ohio
-
Nano® Hearing Aids and Soundwave Hearing Forge Strategic Partnership to Expand Accessibility to Sontro® Self-Fitting OTC Hearing Aid
-
Gabelli Funds to Host 16th Annual Media & Entertainment Symposium Thursday, June 6, 2024
-
Kratos Defense Celebrates the 200th Launch of the BQM-177A in Support of U.S. Navy Exercises
-
Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company’s Growth
-
Gabelli Funds to Host 16th Annual Media & Entertainment Symposium Thursday, June 6, 2024
-
LevLane Advertising Wins PRSA Anvil Award for Best Feature Article Addressing Bias Against Use of Biological Terms in Women's Health Marketing and Advertising
-
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
Decisions of the Annual General Meeting of AS Pro Kapital Grupp shareholders
-
Wood Mackenzie names new leader for Consulting
-
Alliance Trust PLC - Net Asset Value
-
NeuralAI Launches AI 3D Asset Generator with TAO Bittensor Subnet: Transforming 3D Model Creation for Games and Beyond
-
CAE, INC. ALERT: CAE, Inc. Falls after Announcing Impairment Charges (NYSE: CAE) – Investors are Encouraged to Contact BFA Law About Your Rights
-
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermat
-
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis
-
Entourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive Quarter
-
Inter&Co doubles down on SMEs through acquisition of Granito
-
Inter&Co doubles down on SMEs through acquisition of Granito
-
WIDEOPENWEST ALERT: WideOpenWest’s $4.80 Per Share Offer from DigitalBridge is Under Investigation (NYSE: WOW) – Contact BFA Law to Discuss How this Impacts You
-
SQUARESPACE ALERT: Squarespace’s $44 Per Share Buyout Offer From Permira is Under Investigation (NYSE: SQSP) - Contact BFA Law to Discuss How this Impacts You
-
Yorbeau Consolidates Interest in Its Beschefer Property
-
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
-
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
-
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
-
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
KANZHUN LIMITED repurchased RMB74 million ordinary shares under its repurchase plan
-
Leading Proxy Advisor ISS Recommends Medallion Shareholders Vote “FOR” Both of the Board’s Director Nominees on the BLUE Proxy Card
-
Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity Requirement
-
Judge Consulting Recognized on 2024 CRN Solution Provider 500 List
-
Venus Concept Announces $35 million Debt-to-Equity Exchange Transaction
-
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
-
PGS ASA: Calling Notice for 2024 Annual General Meeting
-
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
-
LEGAL DEADLINE ALERT: Sprout Social (Nasdaq: SPT) Investors are Encouraged to Contact BFA Law before July Deadline in Securities Class Action after Stock Tumbled Over 40%
-
CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: CERE) – Contact BFA Law to Discuss How this Impacts You
-
Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
-
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
-
Gold Royalty Announces Agreement to Acquire Vares Copper Stream
-
Gold Royalty Announces US$30 Million Bought Deal Financing
-
Invesco Ltd: Form 8.3 - BHP Group Ltd. Public dealing disclosure
-
Key information relating to the cash dividend to be paid by Golar LNG Limited (Ticker: GLNG)
-
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
-
Golar LNG Limited Interim results for the period ended March 31 2024

